Target intelligence / Profile preview

Physiologic extracellular matrix and adipose tissue compartments

Molecular classification
Other
01

Overview

The physiologic extracellular matrix (ECM) and adipose tissue compartments represent distinct yet interacting histological environments essential for tissue architecture and metabolic health. The ECM is a complex, dynamic scaffold of fibrous proteins, proteoglycans, and glycoproteins that regulates cell behavior, mechanical properties, and tissue homeostasis (NCBI, 2022). Adipose tissue functions as a specialized connective tissue and a major metabolic hub, storing lipids and acting as an endocrine organ by releasing hormones like leptin and adiponectin (StatPearls, 2023). These compartments are frequently implicated in the progression of chronic diseases, including systemic fibrosis, metabolic syndrome, and the tumor microenvironment, where they influence drug penetration and cellular resistance (PubMed, 2021). Because they are broad tissue classifications rather than discrete molecular entities, they are generally not classified as individual therapeutic targets. However, they contain numerous druggable proteins such as integrins, collagenases, and metabolic receptors that are targeted to treat specific pathologies. In pharmacological research, these compartments are primarily studied to understand drug distribution, bioavailability, and the impact of the microenvironment on therapeutic efficacy. Understanding the interplay between the ECM and adipose tissue is also crucial for regenerative medicine and tissue engineering applications.

Other names
Extracellular matrixAdipose tissueECMConnective tissue matrixFatty tissue
02

Mechanism of action

Not applicable as this represents a tissue compartment or histological environment rather than a specific molecular target.

03

Biological functions

Structural supportMetabolic regulationCell signalingEnergy storageTissue homeostasisEndocrine signaling
04

Disease associations

ObesityFibrosisCancerMetabolic syndromeLipodystrophyScleroderma
05

Safety considerations

Non-specific tissue degradationSystemic metabolic disruptionImpaired wound healingFibrotic response to injury
06

Biomarkers

Collagen type I fragmentsAdiponectinLeptinMatrix metalloproteinases (MMPs)Procollagen type III N-terminal peptide (PIIINP)

Beyond the preview

Go deeper on Physiologic extracellular matrix and adipose tissue compartments.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Physiologic extracellular matrix and adipose tissue compartments.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call